Topic Review
Natural Chalcones and Derivatives in Colon Cancer
Colon cancer poses a complex and substantial global health challenge, necessitating innovative therapeutic approaches. Chalcones, a versatile class of compounds with diverse pharmacological properties, have emerged as promising candidates for addressing colon cancer. Their ability to modulate pivotal signaling pathways in the development and progression of colon cancer makes them invaluable as targeted therapeutics. Nevertheless, it is crucial to recognize that although chalcones exhibit promise, further pre-clinical studies are required to validate their efficacy and safety. The journey toward effective colon cancer treatment is multifaceted, involving considerations such as optimizing the sequencing of therapeutic agents, comprehending the resistance mechanisms, and exploring combination therapies incorporating chalcones.
  • 202
  • 06 Dec 2023
Topic Review
Nanotoxicity in Human Primary and Cancer Cells
Nanomaterial toxicity tests using normal and cancer cells may yield markedly different results. Nanomaterial toxicity between cancer and primary human cells was compared to determine the basic cell line selection criteria for nanomaterial toxicity analyses.
  • 959
  • 31 Mar 2022
Topic Review
Nanotechnology-Assisted Cell Tracking
The beneficial effects of nanotechnology in the field of disease diagnosis and therapy depends on the evolution of innovative approaches for cell tracking in living subjects. Recent developments in the use of nanotechnologies have contributed to advance of the high-resolution in vivo imaging methods as well as targeted disease approaches. In this context, the application of strategies for the biomimetic design and functionalization of nanoparticles (NP) to be used for directing cell labelling and their intracellular retention have received growing interest and require further investigation to improve direct cell tracking protocols allowing non-invasive long-term targeted monitoring through in vivo imaging.
  • 586
  • 05 May 2022
Topic Review
Nanoparticles to Treat Macrophages
Nanoparticles are nanomaterials with three external nanoscale dimensions and an average size ranging from 1 to 1000 nm. Nanoparticles have gained notoriety in technological advances due to their tunable physical, chemical, and biological characteristics. However, the administration of functionalized nanoparticles to living beings is still challenging due to the rapid detection and blood and tissue clearance by the mononuclear phagocytic system. The major exponent of this system is the macrophage. Regardless the nanomaterial composition, macrophages can detect and incorporate foreign bodies by phagocytosis. Therefore, the simplest explanation is that any injected nanoparticle will be probably taken up by macrophages. This explains, in part, the natural accumulation of most nanoparticles in the spleen, lymph nodes, and liver (the main organs of the mononuclear phagocytic system). For this reason, recent investigations are devoted to design nanoparticles for specific macrophage targeting in diseased tissues. The aim of this review is to describe current strategies for the design of nanoparticles to target macrophages and to modulate their immunological function involved in different diseases with special emphasis on chronic inflammation, tissue regeneration, and cancer. 
  • 419
  • 02 Sep 2021
Topic Review
Nanoparticles in Pediatric Brain Tumors' Cancer Stem Cells
Primary malignant brain tumors are the most common solid neoplasm in childhood. Despite recent advances, many children affected by aggressive or metastatic brain tumors still present poor prognosis, therefore the development of more effective therapies is urgent. Cancer stem cells (CSCs) have been discovered and isolated in both pediatric and adult patients with brain tumors (e.g., medulloblastoma, gliomas and ependymoma). CSCs are a small clonal population of cancer cells responsible for brain tumor initiation, maintenance and progression, displaying resistance to conventional anticancer therapies. CSCs are characterized by a specific repertoire of surface markers and intracellular specific pathways. These unique features of CSCs biology offer the opportunity to build therapeutic approaches to specifically target these cells in the complex tumor bulk.
  • 442
  • 15 Mar 2023
Topic Review
Nanoparticles in Lung Cancer Treatment
Lung cancer is managed using conventional therapies, including chemotherapy, radiation therapy, or a combination of both. Each of these therapies has its own limitations, such as the indiscriminate killing of normal as well as cancer cells, the solubility of the chemotherapeutic drugs, rapid clearance of the drugs from circulation before reaching the tumor site, the resistance of cancer cells to radiation, and over-sensitization of normal cells to radiation. Other treatment modalities include gene therapy, immunological checkpoint inhibitors, drug repurposing, and in situ cryo-immune engineering (ICIE) strategy. Nanotechnology has come to the rescue to overcome many shortfalls of conventional therapies.
  • 472
  • 06 Jul 2023
Topic Review
Nanomaterials Acting on Natural Killer Cells
Tumor immunotherapy, which includes immune target inhibition and chimeric antigen receptor cell treatment, is currently evolving quickly. Among them, natural killer (NK) cells are gradually becoming another preferred cell immunotherapy after T cell immunotherapy due to their unique killing effects in innate and adaptive immunity. NK cell therapy has shown encouraging outcomes in clinical studies; however, there are still some problems, including limited efficacy in solid tumors, inadequate NK cell penetration, and expensive treatment expenses. Noteworthy benefits of nanomaterials include their chemical specificity, biocompatibility, and ease of manufacturing; these make them promising instruments for enhancing NK cell anti-tumor immune responses. Nanomaterials can promote NK cell homing and infiltration, participate in NK cell modification and non-invasive cell tracking and imaging modes, and greatly increase the effectiveness of NK cell immunotherapy. 
  • 536
  • 13 Mar 2024
Topic Review
Nanobodies
Nanobodies are highly water-soluble and stable, have high specificity, and can bind their targets with very high affinity, often in the low nanomolar range. 
  • 1.6K
  • 10 May 2021
Topic Review
NADPH Oxidases
NADPH oxidases (NOXs), mostly known as respiratory burst oxidase homologs (RBOHs), are the key producers of reactive oxygen species (ROS) in plants. A lot of literature has addressed ROS signaling in plant development regulation and stress responses as well as on the enzyme’s structure, evolution, function, regulation and associated mechanisms, manifesting the role of NOXs/RBOHs as the vital performers and center hubs during plant growth and signaling.
  • 572
  • 20 May 2021
Topic Review
N-Terminal Methionine Excision
In the cytosol of human cells, when a newly synthesized polypeptide emerges from the ribosomes, its fate can be determined by the enzymes that modify its N-terminal α-amino acid residue (Nα). These N-terminal modifications include excision of the initiator methionine (iMet), Nα-myristoylation, Nα-acetylation, Nα-methylation, and other less common modification events. Methionine aminopeptidases (MetAPs) are responsible for N-terminal iMet excision (NME).
  • 281
  • 14 Aug 2023
  • Page
  • of
  • 161
ScholarVision Creations